Effects of smoking abstinence on visuospatial working memory function in schizophrenia
- PMID: 11751034
- DOI: 10.1016/S0893-133X(01)00296-2
Effects of smoking abstinence on visuospatial working memory function in schizophrenia
Abstract
Schizophrenic patients have impairments in cognitive function, including deficits in visuospatial working memory (VSWM). VSWM is mediated, in part, by prefrontal cortical dopamine (DA) function, and dysregulation of prefrontal cortical DA systems may contribute to the pathophysiology of schizophrenia. Nicotine has complex effects on spatial working memory (SWM) in animal studies, with most studies demonstrating enhancement of SWM. Cigarette smoking is highly prevalent in schizophrenia, and these patients may smoke cigarettes to remediate cognitive deficits. The present study examined the effects of acute (<1 week) and prolonged (8-10 weeks) smoking abstinence on VSWM in schizophrenic (n = 23) and control (n = 29) nicotine-dependent cigarette smokers during placebo-controlled smoking cessation trials. Schizophrenic and control smoking patients had significant impairments in VSWM compared to non-smoking controls, after adjusting for differences in age, education and depressive symptoms. Schizophrenic smokers who quit smoking had further impairments in VSWM, and control quitters had improvements in VSWM. Abstinence-induced changes in VSWM varied as a function of gender in controls, but not in schizophrenics. These changes in VSWM appeared to be independent of study medications, and smoking abstinence did not significantly alter performance on the Stroop Color Word Test in either group. These results suggest that smoking abstinence differentially alters VSWM in schizophrenic vs. control smokers, and that cigarette smoking has beneficial effects on VSWM in schizophrenic, but not control, smokers.
Comment in
-
Are differential behavioral responses to smoking and smoking cessation in schizophrenia related to nicotinic receptor levels?Neuropsychopharmacology. 2002 Dec;27(6):1082-3; author reply 1084-5. doi: 10.1016/S0893-133X(02)00382-2. Neuropsychopharmacology. 2002. PMID: 12464465 No abstract available.
Similar articles
-
Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia.Schizophr Res. 2004 Oct 1;70(2-3):263-75. doi: 10.1016/j.schres.2004.01.006. Schizophr Res. 2004. PMID: 15329302 Clinical Trial.
-
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.Arch Gen Psychiatry. 2005 Jun;62(6):649-59. doi: 10.1001/archpsyc.62.6.649. Arch Gen Psychiatry. 2005. PMID: 15939842
-
The short term effect of nicotine abstinence on visuospatial working memory in smoking patients with schizophrenia.Nord J Psychiatry. 2013 Apr;67(2):104-8. doi: 10.3109/08039488.2012.687765. Epub 2012 Jul 5. Nord J Psychiatry. 2013. PMID: 22762200 Clinical Trial.
-
[Smoking reduction and temporary abstinence: new approaches for smoking cessation].J Mal Vasc. 2003 Dec;28(5):293-300. J Mal Vasc. 2003. PMID: 14978435 Review. French.
-
[A review of the effects of nicotine on schizophrenia].Psychiatr Pol. 2007 Sep-Oct;41(5):737-44. Psychiatr Pol. 2007. PMID: 18421928 Review. Polish.
Cited by
-
C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.Psychopharmacology (Berl). 2006 Nov;188(4):530-40. doi: 10.1007/s00213-006-0469-1. Epub 2006 Aug 9. Psychopharmacology (Berl). 2006. PMID: 16896957 Clinical Trial.
-
Co-morbidity of smoking in patients with psychiatric and substance use disorders.Am J Addict. 2005 Mar-Apr;14(2):106-23. doi: 10.1080/10550490590924728. Am J Addict. 2005. PMID: 16019961 Free PMC article. Review.
-
Cognitive performance and cigarette smoking in first-episode psychosis.Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):65-71. doi: 10.1007/s00406-008-0835-6. Epub 2008 Jun 26. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 18584231
-
Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.Nicotine Tob Res. 2020 Feb 6;22(2):204-212. doi: 10.1093/ntr/ntz048. Nicotine Tob Res. 2020. PMID: 30899959 Free PMC article.
-
Nicotine improves delayed recognition in schizophrenic patients.Psychopharmacology (Berl). 2004 Jul;174(3):334-40. doi: 10.1007/s00213-003-1764-8. Epub 2004 Mar 2. Psychopharmacology (Berl). 2004. PMID: 14997272 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical